This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Dec 28;306(24):2727-8.

doi: 10.1001/jama.2011.1865.

Pharmacogenomics and clopidogrel: irrational exuberance?

Steven E Nissen

PMID: 22203545
DOI: 10.1001/jama.2011.1865

Editorial

Pharmacogenomics and clopidogrel: irrational exuberance?

Steven E Nissen. JAMA. 2011.

. 2011 Dec 28;306(24):2727-8.

doi: 10.1001/jama.2011.1865.

Author

Steven E Nissen

PMID: 22203545
DOI: 10.1001/jama.2011.1865

No abstract available

PubMed Disclaimer

Comment in

CYP2C19 genotype and cardiovascular events.
Shuldiner AR, Vesely MR, Fisch A. Shuldiner AR, et al. JAMA. 2012 Apr 11;307(14):1482; author reply 1484-5. doi: 10.1001/jama.2012.443. JAMA. 2012. PMID: 22496255 No abstract available.

Comment on

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.
Holmes MV, Perel P, Shah T, Hingorani AD, Casas JP. Holmes MV, et al. JAMA. 2011 Dec 28;306(24):2704-14. doi: 10.1001/jama.2011.1880. JAMA. 2011. PMID: 22203539 Review.

Similar articles

CYP2C19 genotype and cardiovascular events.
Siasos G, Tousoulis D, Stefanadis C. Siasos G, et al. JAMA. 2012 Apr 11;307(14):1483-4; author reply 1484-5. doi: 10.1001/jama.2012.445. JAMA. 2012. PMID: 22496257 No abstract available.
CYP2C19 genotype and cardiovascular events.
Mega JL, Topol EJ, Sabatine MS. Mega JL, et al. JAMA. 2012 Apr 11;307(14):1482-3; author reply 1484-5. doi: 10.1001/jama.2012.444. JAMA. 2012. PMID: 22496256 No abstract available.
CYP2C19 genotype and cardiovascular events.
Shuldiner AR, Vesely MR, Fisch A. Shuldiner AR, et al. JAMA. 2012 Apr 11;307(14):1482; author reply 1484-5. doi: 10.1001/jama.2012.443. JAMA. 2012. PMID: 22496255 No abstract available.
CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.
Holmes MV, Perel P, Shah T, Hingorani AD, Casas JP. Holmes MV, et al. JAMA. 2011 Dec 28;306(24):2704-14. doi: 10.1001/jama.2011.1880. JAMA. 2011. PMID: 22203539 Review.
Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient).
Wynn RL. Wynn RL. Gen Dent. 2010 Jan-Feb;58(1):7-9. Gen Dent. 2010. PMID: 20129886 Review. No abstract available.

See all similar articles

Cited by

The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.
Lopez-Medina AI, Chahal CAA, Luzum JA. Lopez-Medina AI, et al. Pharmacogenomics. 2022 Jun;23(9):543-557. doi: 10.2217/pgs-2022-0027. Epub 2022 Jun 14. Pharmacogenomics. 2022. PMID: 35698903 Free PMC article. Review.
Moving Pharmacogenetics Into Practice: It's All About the Evidence!
Luzum JA, Petry N, Taylor AK, Van Driest SL, Dunnenberger HM, Cavallari LH. Luzum JA, et al. Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327. Epub 2021 Jul 7. Clin Pharmacol Ther. 2021. PMID: 34101169 Free PMC article. Review.
In vitro Research Concerning Effect of Clopidogrel Alone and on Combination with Aspirin and Dypiridamoleon Sedimentation of Erythrocytes.
Borisova S, Sarbu I, Mati E, Savu SN. Borisova S, et al. Curr Health Sci J. 2017 Jan-Mar;43(1):12-19. doi: 10.12865/CHSJ.43.01.02. Epub 2017 Sep 27. Curr Health Sci J. 2017. PMID: 30595849 Free PMC article.
Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations.
Luzum JA, Cheung JC. Luzum JA, et al. Pharmacogenomics. 2018 Oct;19(15):1203-1216. doi: 10.2217/pgs-2018-0097. Epub 2018 Sep 10. Pharmacogenomics. 2018. PMID: 30196751 Free PMC article.
Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Lee CR, Sriramoju VB, Cervantes A, Howell LA, Varunok N, Madan S, Hamrick K, Polasek MJ, Lee JA, Clarke M, Cicci JD, Weck KE, Stouffer GA. Lee CR, et al. Circ Genom Precis Med. 2018 Apr;11(4):e002069. doi: 10.1161/CIRCGEN.117.002069. Circ Genom Precis Med. 2018. PMID: 29615454 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information